Download presentation
Presentation is loading. Please wait.
Published byClaude McBride Modified over 6 years ago
1
Hypoplastic Left Heart Syndrome Is Not a Predictor of Worse Intermediate Mortality Post Fontan
Billie-Jean Martin, MD, PhD, Kandice Mah, MD, Luke Eckersley, MBBS, Joyce Harder, MD, Charissa Pockett, MD, Daryl Schantz, MD, John Dyck, MD, Mohammed Al Aklabi, MD, Ivan M. Rebeyka, MD, David B. Ross, MD The Annals of Thoracic Surgery Volume 104, Issue 6, Pages (December 2017) DOI: /j.athoracsur Copyright © Terms and Conditions
2
The Annals of Thoracic Surgery 2017 104, 2037-2044DOI: (10. 1016/j
The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © Terms and Conditions
3
Fig 1 Survival stratified by hypoplastic left heart syndrome status. (A) Overall survival (p = 0.385). (B) Transplant-free survival (p = 0.250). (C) Transplant-free survival in propensity-matched cohort (p = ). (HLHS = hypoplastic left heart syndrome.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © Terms and Conditions
4
Fig 2 Freedom from late surgical reintervention by hypoplastic left heart syndrome status (p = 0.771). (HLHS = hypoplastic left heart syndrome.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.